clobetasol and Hypertension

clobetasol has been researched along with Hypertension* in 5 studies

Reviews

2 review(s) available for clobetasol and Hypertension

ArticleYear
Erosive pustular dermatosis of the leg: an uncommon entity?
    Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2017, Volume: 152, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Clobetasol; Erythema; Humans; Hypertension; Leg Injuries; Leg Ulcer; Male; Middle Aged; Recurrence; Skin Diseases, Vesiculobullous; Venous Insufficiency

2017
Lichen planus pemphigoides: a case report and review of the literature.
    Dermatology online journal, 2006, May-30, Volume: 12, Issue:4

    Topics: Adrenal Cortex Hormones; Adult; Age of Onset; Anti-Inflammatory Agents; Clobetasol; Contraindications; Diabetes Complications; Female; Humans; Hypertension; Lichen Planus; Obesity; Ointments; Pemphigoid, Bullous

2006

Trials

1 trial(s) available for clobetasol and Hypertension

ArticleYear
[Benefit of topical steroids in necrotic angiodermatitis].
    Annales de dermatologie et de venereologie, 2003, Volume: 130, Issue:5

    Topics: Administration, Topical; Aged; Anti-Inflammatory Agents; Clobetasol; Dermatitis; Female; Glucocorticoids; Humans; Hypertension; Ischemia; Male; Necrosis; Skin Ulcer

2003

Other Studies

2 other study(ies) available for clobetasol and Hypertension

ArticleYear
[Replacing systemic with topical corticotherapy in patients with generalized bullous pemphigoid and serious steroid-induced iatrogenesis].
    Actas dermo-sifiliograficas, 2006, Volume: 97, Issue:3

    We describe four patients with generalized bullous pemphigoid, who received treatment with oral prednisone and suffered serious corticosteroid-induced iatrogenesis. In all cases, we decided to quickly withdraw the systemic corticosteroid treatment and begin treatment with 0.05 % clobetasol propionate (20 g/day). New outbreaks of pemphigoid or significant side effects were not seen after this change in medication. The topical treatment went on for five to twelve months, and the patients were followed up for extended periods after treatment ended, with no recurrences being observed. Systemic corticosteroid treatment may be replaced by topical treatment without complications, and this may be especially indicated in patients with serious corticosteroid-induced iatrogenesis.

    Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Amputation, Surgical; Clobetasol; Comorbidity; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Iatrogenic Disease; Immunosuppressive Agents; Ischemia; Leg; Pemphigoid, Bullous; Pneumonia; Prednisone; Stroke

2006
Long-term cyclosporine in the management of psoriasis.
    Transplantation proceedings, 1988, Volume: 20, Issue:3 Suppl 4

    Topics: Clobetasol; Creatinine; Cyclosporins; Drug Evaluation; Drug Therapy, Combination; Humans; Hypertension; Psoriasis

1988